TPSF
SCLN

Texas Permanent School Fund’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Texas Permanent School Fund’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-38,102
Closed -$427K – 1527
2017
Q3 		$427K Buy
38,102
+332
+0.9% +$3.66K 0.01% 1391
2017
Q2 		$415K Buy
37,770
+502
+1% +$5.02K 0.01% 1387
2017
Q1 		$365K Buy
37,268
+32
+0.1% +$320 ﹤0.01% 1397
2016
Q4 		$402K Sell
37,236
-807
-2% -$8.07K 0.01% 1389
2016
Q3 		$390K Sell
38,043
-119
-0.3% -$1.3K 0.01% 1381
2016
Q2 		$498K Buy
+38,162
New +$500K 0.01% 1307

Texas Permanent School Fund's SCLN Position: Q4 2017 in Review

Texas Permanent School Fund sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 38,102 shares — an estimated $427K sold.

Texas Permanent School Fund first reported a position in SCLN in Q2 2016 and held it in 6 quarters. The position peaked at $498K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Texas Permanent School Fund reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Texas Permanent School Fund sold 38,102 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $427K.
  • Texas Permanent School Fund first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 6 quarters.
  • Texas Permanent School Fund's Sciclone Pharmaceuticals Inc position peaked at $498K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Texas Permanent School Fund's 13F filing for Q4 2017, filed 23 Jan 2018.